Anthrax as a biological weapon, 2002: Updated recommendations for management

Thomas V. Inglesby, Tara O'Toole, Donald A. Henderson, John G. Bartlett, Michael S. Ascher, Edward Eitzen, Arthur M. Friedlander, Julie Gerberding, Jerome Hauer, James Hughes, Joseph McDade, Michael T. Osterholm, Gerald Parker, Trish M. Perl, Philip K. Russell, Kevin Tonat

Research output: Contribution to journalReview article

812 Citations (Scopus)

Abstract

Objective: To review and update consensus-based recommendations for medical and public health professionals following a Bacillus anthracis attack against a civilian population. Participants: The working group included 23 experts from academic medical centers, research organizations and governmental, military, public health, and emergency management institutions and agencies. Evidence: MEDLINE databases were searched from January 1966 to January 2002, using the Medical Subject Headings anthrax, Bacillus anthracis, biological weapon, biological terrorism, biological warfare, and biowarfare. Reference review identified work published before 1966. Participants identified unpublished sources. Consensus Process: The first draft synthesized the gathered information. Written comments were incorporated into subsequent drafts. The final statement incorporated all relevant evidence from the search along with consensus recommendations. Conclusions: Specific recommendations include diagnosis of anthrax infection, indications for vaccination, therapy, postexposure prophylaxis, decontamination of the environment, and suggested research. This revised consensus statement presents new information based on the analysis of the anthrax attacks of 2001, including developments in the investigation of the anthrax attacks of 2001; important symptoms, signs, and laboratory studies; new diagnostic clues that may help future recognition of this disease; current anthrax vaccine information; updated antibiotic therapeutic considerations; and judgments about environmental surveillance and decontamination.

Original languageEnglish (US)
Pages (from-to)2236-2252
Number of pages17
JournalJournal of the American Medical Association
Volume287
Issue number17
StatePublished - May 1 2002

Fingerprint

Biological Warfare Agents
Anthrax
Consensus
Bacillus anthracis
Decontamination
Biological Warfare
Anthrax Vaccines
Public Health
Medical Subject Headings
Bioterrorism
Environmental Monitoring
MEDLINE
Signs and Symptoms
Biomedical Research
Vaccination
Emergencies
Organizations
Databases
Anti-Bacterial Agents
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Inglesby, T. V., O'Toole, T., Henderson, D. A., Bartlett, J. G., Ascher, M. S., Eitzen, E., ... Tonat, K. (2002). Anthrax as a biological weapon, 2002: Updated recommendations for management. Journal of the American Medical Association, 287(17), 2236-2252.

Anthrax as a biological weapon, 2002 : Updated recommendations for management. / Inglesby, Thomas V.; O'Toole, Tara; Henderson, Donald A.; Bartlett, John G.; Ascher, Michael S.; Eitzen, Edward; Friedlander, Arthur M.; Gerberding, Julie; Hauer, Jerome; Hughes, James; McDade, Joseph; Osterholm, Michael T.; Parker, Gerald; Perl, Trish M.; Russell, Philip K.; Tonat, Kevin.

In: Journal of the American Medical Association, Vol. 287, No. 17, 01.05.2002, p. 2236-2252.

Research output: Contribution to journalReview article

Inglesby, TV, O'Toole, T, Henderson, DA, Bartlett, JG, Ascher, MS, Eitzen, E, Friedlander, AM, Gerberding, J, Hauer, J, Hughes, J, McDade, J, Osterholm, MT, Parker, G, Perl, TM, Russell, PK & Tonat, K 2002, 'Anthrax as a biological weapon, 2002: Updated recommendations for management', Journal of the American Medical Association, vol. 287, no. 17, pp. 2236-2252.
Inglesby TV, O'Toole T, Henderson DA, Bartlett JG, Ascher MS, Eitzen E et al. Anthrax as a biological weapon, 2002: Updated recommendations for management. Journal of the American Medical Association. 2002 May 1;287(17):2236-2252.
Inglesby, Thomas V. ; O'Toole, Tara ; Henderson, Donald A. ; Bartlett, John G. ; Ascher, Michael S. ; Eitzen, Edward ; Friedlander, Arthur M. ; Gerberding, Julie ; Hauer, Jerome ; Hughes, James ; McDade, Joseph ; Osterholm, Michael T. ; Parker, Gerald ; Perl, Trish M. ; Russell, Philip K. ; Tonat, Kevin. / Anthrax as a biological weapon, 2002 : Updated recommendations for management. In: Journal of the American Medical Association. 2002 ; Vol. 287, No. 17. pp. 2236-2252.
@article{6910ea6c4f2742ca83db05b445a1d963,
title = "Anthrax as a biological weapon, 2002: Updated recommendations for management",
abstract = "Objective: To review and update consensus-based recommendations for medical and public health professionals following a Bacillus anthracis attack against a civilian population. Participants: The working group included 23 experts from academic medical centers, research organizations and governmental, military, public health, and emergency management institutions and agencies. Evidence: MEDLINE databases were searched from January 1966 to January 2002, using the Medical Subject Headings anthrax, Bacillus anthracis, biological weapon, biological terrorism, biological warfare, and biowarfare. Reference review identified work published before 1966. Participants identified unpublished sources. Consensus Process: The first draft synthesized the gathered information. Written comments were incorporated into subsequent drafts. The final statement incorporated all relevant evidence from the search along with consensus recommendations. Conclusions: Specific recommendations include diagnosis of anthrax infection, indications for vaccination, therapy, postexposure prophylaxis, decontamination of the environment, and suggested research. This revised consensus statement presents new information based on the analysis of the anthrax attacks of 2001, including developments in the investigation of the anthrax attacks of 2001; important symptoms, signs, and laboratory studies; new diagnostic clues that may help future recognition of this disease; current anthrax vaccine information; updated antibiotic therapeutic considerations; and judgments about environmental surveillance and decontamination.",
author = "Inglesby, {Thomas V.} and Tara O'Toole and Henderson, {Donald A.} and Bartlett, {John G.} and Ascher, {Michael S.} and Edward Eitzen and Friedlander, {Arthur M.} and Julie Gerberding and Jerome Hauer and James Hughes and Joseph McDade and Osterholm, {Michael T.} and Gerald Parker and Perl, {Trish M.} and Russell, {Philip K.} and Kevin Tonat",
year = "2002",
month = "5",
day = "1",
language = "English (US)",
volume = "287",
pages = "2236--2252",
journal = "JAMA - Journal of the American Medical Association",
issn = "0098-7484",
publisher = "American Medical Association",
number = "17",

}

TY - JOUR

T1 - Anthrax as a biological weapon, 2002

T2 - Updated recommendations for management

AU - Inglesby, Thomas V.

AU - O'Toole, Tara

AU - Henderson, Donald A.

AU - Bartlett, John G.

AU - Ascher, Michael S.

AU - Eitzen, Edward

AU - Friedlander, Arthur M.

AU - Gerberding, Julie

AU - Hauer, Jerome

AU - Hughes, James

AU - McDade, Joseph

AU - Osterholm, Michael T.

AU - Parker, Gerald

AU - Perl, Trish M.

AU - Russell, Philip K.

AU - Tonat, Kevin

PY - 2002/5/1

Y1 - 2002/5/1

N2 - Objective: To review and update consensus-based recommendations for medical and public health professionals following a Bacillus anthracis attack against a civilian population. Participants: The working group included 23 experts from academic medical centers, research organizations and governmental, military, public health, and emergency management institutions and agencies. Evidence: MEDLINE databases were searched from January 1966 to January 2002, using the Medical Subject Headings anthrax, Bacillus anthracis, biological weapon, biological terrorism, biological warfare, and biowarfare. Reference review identified work published before 1966. Participants identified unpublished sources. Consensus Process: The first draft synthesized the gathered information. Written comments were incorporated into subsequent drafts. The final statement incorporated all relevant evidence from the search along with consensus recommendations. Conclusions: Specific recommendations include diagnosis of anthrax infection, indications for vaccination, therapy, postexposure prophylaxis, decontamination of the environment, and suggested research. This revised consensus statement presents new information based on the analysis of the anthrax attacks of 2001, including developments in the investigation of the anthrax attacks of 2001; important symptoms, signs, and laboratory studies; new diagnostic clues that may help future recognition of this disease; current anthrax vaccine information; updated antibiotic therapeutic considerations; and judgments about environmental surveillance and decontamination.

AB - Objective: To review and update consensus-based recommendations for medical and public health professionals following a Bacillus anthracis attack against a civilian population. Participants: The working group included 23 experts from academic medical centers, research organizations and governmental, military, public health, and emergency management institutions and agencies. Evidence: MEDLINE databases were searched from January 1966 to January 2002, using the Medical Subject Headings anthrax, Bacillus anthracis, biological weapon, biological terrorism, biological warfare, and biowarfare. Reference review identified work published before 1966. Participants identified unpublished sources. Consensus Process: The first draft synthesized the gathered information. Written comments were incorporated into subsequent drafts. The final statement incorporated all relevant evidence from the search along with consensus recommendations. Conclusions: Specific recommendations include diagnosis of anthrax infection, indications for vaccination, therapy, postexposure prophylaxis, decontamination of the environment, and suggested research. This revised consensus statement presents new information based on the analysis of the anthrax attacks of 2001, including developments in the investigation of the anthrax attacks of 2001; important symptoms, signs, and laboratory studies; new diagnostic clues that may help future recognition of this disease; current anthrax vaccine information; updated antibiotic therapeutic considerations; and judgments about environmental surveillance and decontamination.

UR - http://www.scopus.com/inward/record.url?scp=0036569530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036569530&partnerID=8YFLogxK

M3 - Review article

C2 - 11980524

AN - SCOPUS:0036569530

VL - 287

SP - 2236

EP - 2252

JO - JAMA - Journal of the American Medical Association

JF - JAMA - Journal of the American Medical Association

SN - 0098-7484

IS - 17

ER -